Christine M. Belden

12.8k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Christine M. Belden is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Christine M. Belden has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 32 papers in Physiology and 28 papers in Psychiatry and Mental health. Recurrent topics in Christine M. Belden's work include Parkinson's Disease Mechanisms and Treatments (30 papers), Alzheimer's disease research and treatments (28 papers) and Dementia and Cognitive Impairment Research (27 papers). Christine M. Belden is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (30 papers), Alzheimer's disease research and treatments (28 papers) and Dementia and Cognitive Impairment Research (27 papers). Christine M. Belden collaborates with scholars based in United States, Taiwan and United Kingdom. Christine M. Belden's co-authors include Sandra A. Jacobson, Holly A. Shill, Charles H. Adler, Thomas G. Beach, Marwan N. Sabbagh, Joseph G. Hentz, John N. Caviness, Michael Malek‐Ahmadi, Erika Driver‐Dunckley and Lucia I. Sue and has published in prestigious journals such as Nature Communications, PLoS ONE and Neurology.

In The Last Decade

Christine M. Belden

66 papers receiving 2.1k citations

Hit Papers

Low clinical diagnostic accuracy of early vs advanced Par... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine M. Belden United States 24 943 692 680 339 317 69 2.2k
Sandra A. Jacobson United States 26 1.0k 1.1× 554 0.8× 547 0.8× 278 0.8× 228 0.7× 60 2.2k
Thaı́s Minett United Kingdom 27 434 0.5× 824 1.2× 575 0.8× 374 1.1× 373 1.2× 72 2.1k
J.-F. Dartigues France 15 638 0.7× 514 0.7× 487 0.7× 173 0.5× 238 0.8× 19 2.0k
Montserrat Alegret Spain 27 503 0.5× 644 0.9× 437 0.6× 396 1.2× 244 0.8× 62 1.7k
Paul C. Donaghy United Kingdom 25 896 1.0× 972 1.4× 960 1.4× 354 1.0× 455 1.4× 76 2.1k
Pietro Tiraboschi Italy 24 926 1.0× 985 1.4× 1.1k 1.6× 587 1.7× 364 1.1× 69 2.7k
José M. Farfel Brazil 26 363 0.4× 743 1.1× 1.0k 1.5× 304 0.9× 379 1.2× 67 2.2k
Sophie Auriacombe France 33 503 0.5× 1.2k 1.8× 672 1.0× 690 2.0× 258 0.8× 62 2.7k
Mark Forrest Gordon United States 24 1.7k 1.8× 656 0.9× 344 0.5× 261 0.8× 229 0.7× 83 2.6k
Otto Pedraza United States 23 553 0.6× 729 1.1× 536 0.8× 498 1.5× 178 0.6× 42 1.7k

Countries citing papers authored by Christine M. Belden

Since Specialization
Citations

This map shows the geographic impact of Christine M. Belden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine M. Belden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine M. Belden more than expected).

Fields of papers citing papers by Christine M. Belden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine M. Belden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine M. Belden. The network helps show where Christine M. Belden may publish in the future.

Co-authorship network of co-authors of Christine M. Belden

This figure shows the co-authorship network connecting the top 25 collaborators of Christine M. Belden. A scholar is included among the top collaborators of Christine M. Belden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine M. Belden. Christine M. Belden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Fang, Daniel S. Peterson, Edward Ofori, et al.. (2025). Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study. Dementia and Geriatric Cognitive Disorders. 1–10.
3.
Tremblay, Cécilia, Charles H. Adler, Holly A. Shill, et al.. (2024). Predicting Post‐Mortem α‐Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia. Movement Disorders Clinical Practice. 12(2). 157–165. 2 indexed citations
4.
Mastenbroek, Sophie E, Jacob W. Vogel, Lyduine E. Collij, et al.. (2024). Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology. Nature Communications. 15(1). 5133–5133. 30 indexed citations
5.
Adler, Charles H., Nan Zhang, Holly A. Shill, et al.. (2024). Conjugal Synucleinopathies: A Clinicopathologic Study. Movement Disorders. 39(7). 1212–1217. 1 indexed citations
6.
Tremblay, Cécilia, Parichita Choudhury, Christine M. Belden, et al.. (2023). The role of sex differences in depression in pathologically defined Alzheimer’s disease. Frontiers in Aging Neuroscience. 15. 1156764–1156764. 7 indexed citations
7.
Roher, Alex E., Chera L. Maarouf, Tyler A. Kokjohn, et al.. (2016). Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab.. PubMed Central. 5(4). 158–170. 12 indexed citations
8.
Lue, Lih‐Fen, Christopher T. Schmitz, Kewei Chen, et al.. (2016). Converging mediators from immune and trophic pathways to identify Parkinson disease dementia. Neurology Neuroimmunology & Neuroinflammation. 3(1). e193–e193. 10 indexed citations
9.
Caviness, John N., Joseph G. Hentz, Christine M. Belden, et al.. (2015). Longitudinal EEG Changes Correlate with Cognitive Measure Deterioration in Parkinson's Disease. Journal of Parkinson s Disease. 5(1). 117–124. 71 indexed citations
10.
Malek‐Ahmadi, Michael, Kewei Chen, Kathryn Davis, et al.. (2015). Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire. Alzheimer s Research & Therapy. 7(1). 1–1. 107 indexed citations
11.
Malek‐Ahmadi, Michael, et al.. (2015). Age- and education-adjusted normative data for the Montreal Cognitive Assessment (MoCA) in older adults age 70–99. Aging Neuropsychology and Cognition. 22(6). 755–761. 120 indexed citations
12.
Postuma, Ronald B., Charles H. Adler, Brittany N. Dugger, et al.. (2015). REM sleep behavior disorder and neuropathology in Parkinson's disease. Movement Disorders. 30(10). 1413–1417. 124 indexed citations
13.
Adler, Charles H., Thomas G. Beach, Joseph G. Hentz, et al.. (2014). Low clinical diagnostic accuracy of early vs advanced Parkinson disease. Neurology. 83(5). 406–412. 365 indexed citations breakdown →
14.
Dugger, Brittany N., Joseph G. Hentz, Charles H. Adler, et al.. (2014). Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers. Journal of Neuropathology & Experimental Neurology. 73(3). 244–252. 54 indexed citations
15.
Malek‐Ahmadi, Michael, Thomas G. Beach, Lucia I. Sue, et al.. (2013). Increased Alzheimer’s Disease Neuropathology is Associated with Type 2 Diabetes and ApoE ε4 Carrier Status. Current Alzheimer Research. 10(6). 654–659. 50 indexed citations
16.
Malek‐Ahmadi, Michael, Kathryn Davis, Christine M. Belden, & Marwan N. Sabbagh. (2012). Comparative Analysis of the Alzheimer Questionnaire (AQ) With the CDR Sum of Boxes, MoCA, and MMSE. Alzheimer Disease & Associated Disorders. 28(3). 296–298. 15 indexed citations
17.
Decourt, Boris, Aaron Walker, Michael Malek‐Ahmadi, et al.. (2012). Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets. 24(3). 235–238. 14 indexed citations
18.
Sabbagh, Marwan, Sandra A. Jacobson, Jatin J. Shah, et al.. (2011). P4‐435: A pilot phase IV open label study investigating the safety and tolerability of switching from the Exelon patch 9.5mg daily to Aricept 23mg daily in patients with moderate to severe AD. Alzheimer s & Dementia. 7(4S_Part_25). 1 indexed citations
19.
Jacobson, Sandra A., Joseph G. Hentz, Christine M. Belden, et al.. (2011). The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores. Dementia and Geriatric Cognitive Disorders. 31(2). 126–131. 187 indexed citations
20.
Sabbagh, Marwan N., Ping He, Sherye A. Sirrel, et al.. (2010). P3‐453: Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_19). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026